
201-500 employees
Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing precision therapies for patients with central nervous system disorders. The company leverages genetic insights and advanced drug discovery platforms to create targeted treatments for rare and severe neurological diseases. Praxis aims to transform the lives of patients by addressing the underlying causes of these disorders with innovative medicines. Their pipeline includes therapies for epilepsy, movement disorders, and other neurological conditions, positioning them as a leader in precision neurology.
đź“‹
🎯
🏖️